ProtoKinetix Inc (PKTX)

[PK holder]

As we head towards the holiday keep in mind that we have a molecule in AAGP that will soon be in front of Health Canada for human trials. To be able to purchase a stock at these levels are few and far between. The CEO has bought millions of shares publicly and privately. If that doesn't tell you he is firmly behind this company and stock and believes we will soon be in clinical trials. If we were at higher levels and waiting to hear about the news we wouldn't be selling we'd be dreaming of even higher prices. You have a chance to buy an option basically at these prices with no expiration. Don't wait for the news to jump in the pool. The water is fine and The end of 2016 and beginning of 2017 will be well worth it.